GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Libra Infusions Ltd (DHA:LIBRAINFU) » Definitions » Net Income From Continuing Operations
中文

Libra Infusions (DHA:LIBRAINFU) Net Income From Continuing Operations : BDT0.00 Mil (TTM As of . 20)


View and export this data going back to . Start your Free Trial

Libra Infusions Net Income From Continuing Operations Definition

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Libra Infusions's net income from continuing operations for the six months ended in . 20 was BDT0.00 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in . 20 was BDT0.00 Mil.


Libra Infusions Net Income From Continuing Operations Historical Data

The historical data trend for Libra Infusions's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Libra Infusions Annual Data
Trend
Net Income From Continuing Operations

Libra Infusions Semi-Annual Data
Net Income From Continuing Operations

Libra Infusions Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Net Income From Continuing Operations for the trailing twelve months (TTM) ended in . 20 was BDT0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Libra Infusions (DHA:LIBRAINFU) Business Description

Traded in Other Exchanges
N/A
Address
I/7, Mirpur Industrial Estate, Rupnagar, Section-2, Dhaka, BGD, 1216
Libra Infusions Ltd is engaged in manufacturing intravenous fluids. It provides products which are used for medical purposes involving surgical operations, loss of blood, weakness, and general hospitalization.

Libra Infusions (DHA:LIBRAINFU) Headlines

No Headlines